Daniel Gallucci of NastLaw LLC is chairing the HarrisMartin Conference on Proton Pump Inhibitor Lawsuits. The conference will be held on June 15, 2016 at the Ritz-Carlton Hotel in Philadelphia.
Along with Mr. Gallucci, featured panelists include Neil D. Overholtz of Aylstock, Witkin, Kreis & Overholtz, PLLC, and Paul J. Pennock of Weitz & Luxenberg P.C.
For more information or to register for the conference, visit HarrisMartin’s website.
This popular class of heartburn drugs includes Nexium, Prilosec, and Prevacid. A study published in the Journal of the American Medical Association showed that people who use proton pump inhibitors have a 20 to 50 percent higher risk of developing chronic kidney disease than people who do not use PPIs.
Drugs like Nexium, Prilosec and Prevacid were already linked to short-term kidney problems, but newer research shows a link between PPIs and chronic, long-term kidney disease.
More frequent use of PPIs can increase the risk of serious kidney injury. The study found that twice-daily use resulted in a 46 percent increased risk of chronic kidney disease, whereas once daily use resulted in a 15 percent increased risk.